Fundz

Onco Immune, Inc. reported raising $3 Million in an amended SEC Form D filing, from an offering of $3 Million

PRIVATEMay 22, 2020

Amount Raised

$3 Million

$3 Million sold, per SEC Form D (first sale May 22, 2020)

Round Type

Seed

RockvilleBiotechnology

Quick answer

OncoImmune, Inc. raised $3 Million in a Seed round, dated May 22, 2020. OncoImmune, Inc. is based in Rockville, Maryland, United States.

How much did OncoImmune, Inc. raise?
OncoImmune, Inc. raised $3 Million in a Seed round on May 22, 2020.
What does OncoImmune, Inc. do?
OncoImmune is a clinical-stage company engages in the discovery and development of biopharmaceuticals for the treatment of cancer.
Where is OncoImmune, Inc. based and how big is it?
OncoImmune, Inc. is based in Rockville, Maryland, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as OncoImmune, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • GeoVax Labs raised $2.4M on July 6, 2020.
  • GestVision, Inc. raised $10M on July 6, 2020.
  • Xpan raised $440K (Seed) on July 6, 2020.
  • ENvue Medical, Inc. raised $450K (Seed) on July 6, 2020.
  • Abcuro raised $7.6M on July 6, 2020.
  • Fate Therapeutics raised $50M on July 6, 2020.

Who to call at OncoImmune, Inc., and when

A new round usually means OncoImmune, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OncoImmune, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OncoImmune, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OncoImmune, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OncoImmune, Inc.

Location

9430 KEY WEST AVE.

Rockville, Maryland, United States

About

OncoImmune is a clinical-stage company engages in the discovery and development of biopharmaceuticals for the treatment of cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OncoImmune, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for OncoImmune, Inc.'s next move

See what Strategic adds

OncoImmune, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.